LEADER 03935nam  2200937z- 450 
001 9910557289503321
005 20231214133239.0
035   $a(CKB)5400000000041145
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69438
035   $a(EXLCZ)995400000000041145
100   $a20202105d2020      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBiomaterial-Related Infections
210   $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020
215   $a1 electronic resource (204 p.)
311   $a3-03943-438-1 
311   $a3-03943-439-X 
330   $aThe use of medical devices (e.g., catheters, implants, and probes) is a common and essential part of medical care for both diagnostic and therapeutic purposes. However, these devices quite frequently lead to the incidence of infections due to the colonization of their abiotic surfaces by biofilm-growing microorganisms, which are progressively resistant to antimicrobial therapies. Several methods based on anti-infective biomaterials that repel microbes have been developed to combat device-related infections. Among these strategies, surface coating with antibiotics (e.g., beta-lactams), natural compounds (e.g., polyphenols), or inorganic elements (e.g., silver and copper nanoparticles) has been widely recognized as exhibiting broad-spectrum bactericidal or bacteriostatic activity. So, in order to achieve a better therapeutic response, it is crucial to understand how these infections are different from others. This will allow us to find new biomaterials characterized by antifouling coatings with repellent properties or low adhesion towards microorganisms, or antimicrobial coatings that are capable of killing microbes approaching the surface, improving biomaterial functionalization strategies and supporting tissues? bio-integration.
606   $aMedicine$2bicssc
610   $aCandida
610   $abiofilms
610   $adiabetes
610   $amedical devices
610   $acandidiasis
610   $ametabolic disorder
610   $ahyperglycemia
610   $ainfection
610   $aCandida glabrata
610   $acandidemia
610   $aechinocandins
610   $aresistance
610   $amicafungin
610   $acaspofungin
610   $ain vivo
610   $atitanium dioxide
610   $ananotubes
610   $aautoclaving
610   $atitanium alloy
610   $abiocompatibility
610   $awettability
610   $amechanical properties
610   $asilver nanoparticles
610   $atitanium dioxide nanotubes
610   $asilver ions release
610   $abiointegration
610   $aantimicrobial activity
610   $apolyethylene terephthalate
610   $aPET
610   $aelectrospinning
610   $ananofibers
610   $aantimicrobial agents
610   $aTaguchi method
610   $aantimicrobial efficiency
610   $acold atmospheric-pressure plasma jet (CAPJ)
610   $aEscherichia coli
610   $aDNA double-strand breaks
610   $ascanning electron microscopy
610   $aTi6Al4V implants
610   $aanodization process
610   $aXPS
610   $agenotoxicity assessment
610   $aanti-inflammatory properties
610   $aoral biofilm
610   $ainfection control
610   $aStreptococcus mutans
610   $aCandida spp.
610   $anatural compounds
610   $aantimicrobial resistance
615  7$aMedicine
700   $aRodrigues$b Ce?lia F$4edt$01324789
702   $aMartins$b Nata?lia$4edt
702   $aRodrigues$b Ce?lia F$4oth
702   $aMartins$b Nata?lia$4oth
906   $aBOOK
912   $a9910557289503321
996   $aBiomaterial-Related Infections$93036301
997   $aUNINA